Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-28 Purchase |
2021-06-30 6:01 pm |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
1,050,000 | $19 | $19,950,000 | 7,692,298 (Indirect) |
View |
| 2021-03-16 Purchase |
2021-03-18 5:11 pm |
Marker Therapeutics Inc. | MRKR | Behbahani Ali 10% Owner |
5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:09 pm |
Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-09-18 Purchase |
2020-09-22 5:42 pm |
Metacrine Inc. | MTCR | Behbahani Ali 10% Owner |
769,230 | $13 | $9,999,990 | 3,060,527 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-28 Conversion |
2021-06-30 6:01 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
30,092,935 | $0 | 7,692,298 (Indirect) |
View |
Ownership |
2021-06-29 9:32 pm |
N/A 2023-12-14 |
CVRx Inc. | CVRX | Behbahani Ali Director |
0 | $0 | 5,244 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:47 pm |
N/A 2031-06-22 |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
47,132 | $0 | 47,132 (Direct) |
View |
Ownership |
2021-06-24 9:23 pm |
N/A N/A |
Bright Health Group Inc. | BHG | Behbahani Ali 10% Owner |
0 | $0 | 69,963,828 (Indirect) |
View |
Ownership |
2021-06-23 9:03 pm |
N/A N/A |
Monte Rosa Therapeutics Inc. | GLUE | Behbahani Ali Director 10% Owner |
0 | $0 | 6,642,298 (Indirect) |
View |
| 2021-06-18 Option Award |
2021-06-22 7:18 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
15,000 | $0 | 3,465,318 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 7:18 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
1,014 | $12.95 | 3,465,318 (Direct) |
View |
| 2021-06-13 Option Award |
2021-06-15 4:25 pm |
N/A 2031-06-12 |
Nkarta Inc. | NKTK | Behbahani Ali Director |
16,511 | $0 | 16,511 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 6:23 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-09 8:52 pm |
N/A 2031-06-06 |
Oyster Point Pharma Inc. | OYST | Behbahani Ali Director |
8,665 | $0 | 15,265 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-22 8:33 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Behbahani Ali Director |
547 | $24.01 | 3,449,304 (Direct) |
View |
Ownership |
2021-03-16 6:29 pm |
N/A N/A |
Savara Inc | SVRA | Behbahani Ali 10% Owner |
0 | $0 | 24,137,931 (Indirect) |
View |
| 2020-09-18 Conversion |
2020-09-22 5:42 pm |
N/A N/A |
Metacrine Inc. | MTCR | Behbahani Ali 10% Owner |
2,291,297 | $0 | 3,060,527 (Indirect) |
View |
Ownership |
2020-09-15 5:25 pm |
N/A N/A |
Metacrine Inc. | MTCR | Behbahani Ali 10% Owner |
0 | $0 | 2,291,297 (Indirect) |
View |
| 2020-08-13 Other |
2020-08-14 4:30 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
71 | $0 | 341 (Direct) |
View |